By Rory McCann, Marketing Manager & Conference Producer, LSN
Like most scientist-entrepreneurs, Reglagene CEO, Richard Austin thought the compelling story of his company and their precision chemotherapy technology would be enough to get the attention of investors. He quickly learned the importance of marketing the company and telling their story was also integral to their growth. His early experiences with RESI served as classroom, arena, and runway to success.
In our interview, Richard references the education he received from Life Science Nation CEO, Dennis Ford. Dennis is hosting the Global Roadshow Prep Course: a hands-on, comprehensive, one-day course designed to set up the early-stage life science executive for success as they conduct their global fundraise. Each class is open to 24 early-stage, fundraising entrepreneurs and includes premier access to RESI Partnering Week, September 13-17.
The Global Roadshow Prep Course takes place Friday, September 3 and September 10. View the agenda and sign up to jumpstart your fundraising through telling your story and connecting with the right investors for you!
By Erika Wu, Business Development Representative, LSN
Launching recent partnerships with Mayo Clinic and Roswell Park Comprehensive Cancer Center, Andrea Wang and her team at AHEAD Medicine is paving the way for blood cancer detection and clinical decisions using AI-powered analytics.
As a 9-time RESI attendee, panelist, and Innovator Pitch Challenge (IPC) participant, we are excited to see where AHEAD is going next. Get in front of AI investors at Digital RESI AI (September 16-17) by pitching your company at Innovator’s Pitch Challenge!
By Erika Wu, Business Development Representative, LSN
What if we could automate and improve medical visits by reducing in-person patient contact, administrative burdens and operation costs? Hear what CEO James Bates and his team at AdviNOW Medical are doing to utilize AR and AI to expand healthcare access to anywhere you are. RESI AI returns September 16-17 with dynamic panels, as well as opportunities to pitch to a live panel of AI investors. Get involved and tell your story at Innovator’s Pitch Challenge! Applications are due by Friday, August 20, so submit yours today!
By Rory McCann, Marketing Manager & Conference Producer, LSN
Every startup operates according to the strengths of its leaders and partners, making it essential for successful companies to be built on the diverse skill sets of their teams. Former Innovation Challenge (now Innovator’s Pitch Challenge) winner, Moexa is a shining example of unique experiences and diverse skills put to the test and passing.
Moexa Director and CEO, Anthony Desir has had a successful career in finance and business development before leading the multi-national drug research and development company, and took the time to share his RESI experience, as well as the tools he’s utilized to lead Moexa and lessons he’s learned along the way. Listen to our conversation and sign up for RESI Partnering Week, September 13-17 to jumpstart your own early-stage fundraising journey. Early bird rates for RESI Partnering Week end Friday, August 6. Register today to save!
By Erika Wu, Business Development Representative, LSN
Is the future of diabetes management here? Learn about what Dr. Marc Rippen and his team at Alertgy are achieving with their patented technology and artificial intelligence (AI) to provide on-demand blood glucose readings. You can also see Alertgy at the Innovator’s Pitch Challenge during the digital RESI Partnering Week, September 13-17. Join RESI AI (September 16-17) for dynamic panels, as well as opportunities to pitch to a live panel of investors. Learn more about how you can get involved and tell your story at Innovator’s Pitch Challenge!
Dr. Karim S. Karim, PhD, PEng, MBA, is the Founder and Chief Technology Officer of KA Imaging. Karim has developed novel X-ray imaging devices and systems since 1998 and has founded multiple startups in the past two decades. He is also a Professor of Engineering at the University of Waterloo where he has raised more than $15M in research grant funding, trained over 40 PhD and MASc students, has co-authored 250+ publications and 50+ patents. Some of the pixel circuit technology he developed during his PhD is now used in ultrasonic fingerprint sensors in mobile phones and tablets.
Erika Wu: How is artificial intelligence incorporated into your product, and where is KA Imaging now?
Dr. Karim S. Karim: KA Imaging is a spin-off company from the University of Waterloo in Canada and specializes in developing innovative X-ray imaging technologies and systems to create solutions for the medical, veterinary and non-destructive test industrial markets. Our vision is innovative X-ray everywhere and our mission is to enable our employees the freedom to innovate and create high performance products, for our customers, using cutting edge advances in X-ray technologies. Artificial Intelligence (AI) is a critical part of ongoing innovation in the X-ray imaging space – it has been shown to help clinicians improve diagnostic accuracy and it has also been used to improve X-ray image quality. Our flagship product is the Reveal 35C, the world’s first portable, single-exposure, dual-energy X-ray detector that enables early detection compared to traditional X-ray solutions. Reveal is vendor-agnostic and can be retrofit onto any fixed or portable X-ray machine. What this means for clinicians is that they can instantly become more effective and efficient with their time recognizing diseases earlier and with greater confidence. What this means for patients is better outcomes so they can go home sooner and safely. Unlike standard X-ray, dual-energy X-ray techniques from our flagship product, Reveal 35C, leverage the wealth of spectral data that is present yet hidden in each conventional X-ray spectrum to achieve better bone and tissue contrast. AI algorithms can leverage this spectrally separated data to achieve more accurate image interpretation and analyses compared to AI algorithms that use only the data obtained from a standard X-ray detector.
We are actively seeking funding up to $25M USD in a Series B financing round. We are also looking for strategic OEM/integrator and distribution partnerships to grow our sales channels in North America and internationally. The Reveal 35C is FDA-cleared, Health Canada-approved, TGA Australia-approved, and is expected to be cleared for sale in Europe next year. Recently, we signed up Alpha Imaging as a distribution partner in the USA as well as a number of international distributors in Australia, Mexico, Malaysia, Indonesia and Pakistan. Reveal 35C was also recognized as a Technology Breakthrough by Premier, a leading technology-driven healthcare improvement company, uniting an alliance of more than 4,100 US hospitals and 200,000 other providers and organizations to transform healthcare. Reveal 35C was also listed in the 2021 WHO Compendium of Innovative Health Technologies.
Erika Wu: If you could describe AI in three words, what would they be? What is a piece of advice you’d give to startup CEOs?
Dr. Karim S. Karim: AI is transformative, helpful, and inevitable. My advice is, “People before things always” or alternately, “Put people ahead of other stuff.” People may forget the content of a conversation you had, but they rarely forget the feeling you’ve left them with, so choose your words and actions wisely.
Erika Wu: What are some challenges you’ve learned from and how have they impacted the future of KA Imaging?
Dr. Karim S. Karim: The medical device field is very unusual because you have to promote your product as innovative to investors and incremental to regulatory bodies simultaneously. Jokes aside, for a technology to translate into a really innovative product, your product must do everything the existing market leader is doing and still improve something. This is why Reveal 35C is simultaneously the world’s best X-ray detector and the world’s first portable dual energy X-ray detector. Our team worked hard to achieve this so that ultimately, we would have a chance to replace every X-ray detector in the world with a Reveal 35C. So our staff designed Reveal 35C to use the same dose, the same X-ray source, and the same clinical workflow as a standard X-ray detector, and we put the entire product into a package that looks, weighs and feels like a standard X-ray detector. Yet, the user can get two extra bone and soft tissue dual-energy X-ray images in addition to the standard X-ray image simultaneously using only one exposure. Reveal 35C is highly innovative because it uses the existing information in the X-ray spectrum (which is ignored by standard X-ray) and provides this to both clinicians and AI software for enhanced decision-making.
By Erika Wu, Business Development Representative, LSN
Past RESI AI panelist, Jonathan Cohen returns to give an update on 20/20 Gene Systems, including an expansion from cancer detection to respiratory and cardiovascular diagnostics. Learn how Jonathan and the team are using Artificial Intelligence (AI) to expand their offerings, and how they’re working to create more opportunities for early-stage diagnostic startups. RESI AI returns September 16-17 with dynamic panels, as well as opportunities to pitch to a live panel of investors. Learn more about how you can get involved and tell your story at Innovator’s Pitch Challenge!